Clinical pharmacology of acetylsalicylic acid as an anti-thrombotic agent
Currently, acetylsalicylic acid (ASA) is one of the main medications in cardiovascular prevention. Preventive ASA therapy has some specific pharmacokinetic and pharmacodynamic features, also depending on the medication form. The maximal ASA effectiveness is observed for low doses of 75-150 mg/d. The...
Saved in:
| Main Authors: | V. V. Rafalsky, A. V. Krikova, A. N. Baglikov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1651 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS
by: V. V. Rafalsky, et al.
Published: (2017-08-01) -
Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01) -
Study of pharmaceutical properties of low-dosage enteric-coated acetylsalicylic acid
by: V. V. Rafalsky, et al.
Published: (2016-02-01) -
Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
by: O. V. Averkov
Published: (2010-04-01) -
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
by: E. N. Dankovtseva
Published: (2015-09-01)